Label: PHENTERMINE HYDROCHLORIDE tablet

  • Category: HUMAN PRESCRIPTION DRUG LABEL

Drug Label Information

Updated January 3, 2018

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

  • Indications & Usage

    Phentermine hydrochloride tablets USP are indicated as a short-term (a few weeks) adjunct in a regimen

    of weight reduction based on exercise, behavioral modification and caloric restriction in the

    management of exogenous obesity for patients with an initial body mass index greater than or equal to

    30 kg/m , or greater than or equal to 27 kg/m in the presence of other risk factors (e.g., controlled

    hypertension, diabetes, hyperlipidemia).
    Below is a chart of body mass index (BMI) based on various heights and weights.

    BMI is calculated by taking the patient's weight, in kilograms (kg), divided by the patient's height, in meters (m), squared. Metric conversions are as follows: pounds ÷ 2.2 = kg; inches x 0.0254 = meters.

    Phentermine Indications and usage

  • Description

    Phentermine hydrochloride USP is a sympathomimetic amine anorectic. Its chemical name is a,a- dimethylphenethylamine hydrochloride. The structural formula is as follows:

    Phentermine hydrochloride USP is a white, odorless, hygroscopic, crystalline powder which is soluble in water and lower alcohols, slightly soluble in chloroform and insoluble in ether.

    Phentermine hydrochloride tablets USP are available as an oral tablet containing 37.5 mg of phentermine hydrochloride USP (equivalent to 30 mg of phentermine base). Each phentermine hydrochloride tablet USP also contains the inactive ingredients microcrystalline cellulose, pregelatinized starch, anhydrous lactose, crospovidone, colloidal silicon dioxide, magnesium stearate, sucrose, corn starch and FD&C Blue #1. Phentermine

  • Package and Display

    52959-0812-21

  • INGREDIENTS AND APPEARANCE
    PHENTERMINE HYDROCHLORIDE 
    phentermine hydrochloride tablet
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:52959-812
    Route of AdministrationORALDEA ScheduleCIV    
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    PHENTERMINE HYDROCHLORIDE (UNII: 0K2I505OTV) (PHENTERMINE - UNII:C045TQL4WP) PHENTERMINE HYDROCHLORIDE37.5 mg
    Product Characteristics
    Colorwhite (Off-white with blue specks) Scoreno score
    ShapeOVALSize10mm
    FlavorImprint Code MP;273
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:52959-812-2121 in 1 BOTTLE; Type 0: Not a Combination Product07/18/2017
    2NDC:52959-812-4545 in 1 CONTAINER; Type 0: Not a Combination Product07/18/2017
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA20306807/18/2017
    Labeler - H.J. Harkins Company, Inc. (147681894)
    Establishment
    NameAddressID/FEIBusiness Operations
    H.J. Harkins Comapny., Inc.147681894repack(52959-812) , relabel(52959-812) , manufacture(52959-812)